Código QR (código de barras bidimensional)

The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia

Gain-of-function mutations of isocitrate dehydrogenases 1/2 (IDH1/2) play crucial roles in the development and progression of acute myeloid leukemia (AML), which provide promising therapeutic targets. Two small molecular inhibitors, ivosidenib and enasidenib have been approved for the treatment of I...

ver descrição completa

Na minha lista:
Principais autores: Xiaomei Zhuang, Han Zhong Pei, Tianwen Li, Junbin Huang, Yao Guo, Yuming Zhao, Ming Yang, Dengyang Zhang, Zhiguang Chang, Qi Zhang, Liuting Yu, Chunxiao He, Liqing Zhang, Yihang Pan, Chun Chen, Yun Chen
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2022-06-01
coleção:Frontiers in Oncology
Assuntos:
cancer metabolism
IDH1
IDH2
acute myeloid leukemia
drug resistance
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fonc.2022.931462/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados